A93S (p.Ala93Ser) variant of TTN (Titin)
A93S (p.Ala93Ser) in TTN (Titin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and population frequency data.
A93S (p.Ala93Ser) variant details
- p.Ala93Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- CADD 24.50
- PolyPhen-2 0.99
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available